Schnieders Capital Management LLC Bristol Myers Squibb CO Transaction History

Schnieders Capital Management LLC

$479 Million
Q1 2024

A detailed history of Schnieders Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Schnieders Capital Management LLC holds 14,247 shares of BMY stock, worth $582,132. This represents 0.16% of its overall portfolio holdings.

Number of Shares

14,247

Previous 14,473 1.56%

Holding current value

$582,132

Previous $742,000 4.04%

% of portfolio

0.16%

Previous 0.17%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$47.98 - $54.4 $10,843 - $12,294	-226 Reduced 1.56%	14,247 $772,000
Q4 2023 Feb 01, 2024	SELL	$48.48 - $57.85 $59,872 - $71,444	-1,235 Reduced 7.86%	14,473 $742,000
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $11,578 - $12,946	-200 Reduced 1.26%	15,708 $911,000
Q2 2023 Aug 01, 2023	BUY	$63.71 - $70.74 $3,886 - $4,315	61 Added 0.38%	15,908 $1.02 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $197,129 - $223,590	3,000 Added 23.35%	15,847 $1.1 Million

Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $738 - $436,451	5,680 Added 79.25%	12,847 $913,000
Q2 2022 Jul 28, 2022	BUY	$72.62 - $79.98 $61,727 - $67,983	850 Added 13.46%	7,167 $552,000
Q1 2022 Apr 27, 2022	SELL	$61.48 - $73.72 $11,988 - $14,375	-195 Reduced 2.99%	6,317 $461,000
Q4 2021 Feb 03, 2022	SELL	$53.63 - $62.52 $37,541 - $43,764	-700 Reduced 9.71%	6,512 $406,000
Q3 2021 Nov 01, 2021	BUY	$59.17 - $69.31 $1,242 - $1,455	21 Added 0.29%	7,212 $427,000
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $6,191 - $6,742	-100 Reduced 1.37%	7,191 $481,000
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $5,774 - $6,543	100 Added 1.39%	7,291 $452,000
Q3 2020 Nov 05, 2020	SELL	$57.43 - $63.64 $4,249 - $4,709	-74 Reduced 1.02%	7,191 $434,000
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $62,988 - $73,639	1,149 Added 18.79%	7,265 $427,000
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $5,800 - $8,428	125 Added 2.09%	6,116 $341,000
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $9,989 - $13,030	203 Added 3.51%	5,991 $385,000
Q3 2019 Nov 07, 2019	SELL	$42.77 - $50.71 $9,623 - $11,409	-225 Reduced 3.74%	5,788 $294,000
Q2 2019 Aug 07, 2019	SELL	$44.62 - $49.34 $30,653 - $33,896	-687 Reduced 10.25%	6,013 $273,000
Q1 2019 May 03, 2019	SELL	$45.12 - $53.8 $27,072 - $32,280	-600 Reduced 8.22%	6,700 $319,000
Q4 2018 Feb 01, 2019	SELL	$48.76 - $63.23 $229,172 - $297,181	-4,700 Reduced 39.17%	7,300 $379,000
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $22,076 - $24,900	400 Added 3.45%	12,000 $745,000
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $171,802 - $214,132	-3,400 Reduced 22.67%	11,600 $642,000
Q1 2018 May 10, 2018	SELL	$59.92 - $68.98 $1,498 - $1,724	-25 Reduced 0.17%	15,000 $949,000
Q4 2017 Feb 08, 2018	BUY	$59.94 - $65.35 $329,670 - $359,424	5,500 Added 57.74%	15,025 $921,000
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $526,065 - $607,123	9,525	9,525 $607,000

Others Institutions Holding BMY

# of Institutions

2,557

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86.9B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schnieders Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schnieders Capital Management LLC with notifications on news.

Account

Schnieders Capital Management LLC Bristol Myers Squibb CO Transaction History